Transcriptional stratification reveals distinct molecular subtypes with treatment-specific outcomes in multiple myeloma patients from the GEM2017FIT trial
Por:
Porlan, A, Ariceta, B, Aguirre-Ruiz, P, De Las Heras, J, Medina, A, Gimenez, A, San Martin-Uriz, P, Larrayoz, MJ, Martinez-Lopez, J, Gonzalez-Calle, V, Puig, N, Calasanz, M, Gutierrez, N, Balari, AS, Romero, MTC, Oriol, A, Ocio, E, Dachs, LR, Bargay, J, Blanchard, MJ, Perianes, VC, Palacios, JJL, Creixenti, JBB, San-Miguel, J, Rodriguez-Otero, P, Mateos, MV and Prosper, F
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Porlan, A:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Ariceta, B:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Aguirre-Ruiz, P:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
De Las Heras, J:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Medina, A:
Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
Gimenez, A:
Hosp 12 Octubre, Hematol Dept, Madrid, Spain
San Martin-Uriz, P:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Larrayoz, MJ:
Clin Univ Navarra, CIMA LAB Diagnost, IdiSNA, Pamplona, Spain
Martinez-Lopez, J:
Hosp 12 Octubre, Hematol Dept, Madrid, Spain
Gonzalez-Calle, V:
Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
Puig, N:
Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
Calasanz, M:
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Clin Univ Navarra, CIMA LAB Diagnost, IdiSNA, Pamplona, Spain
Gutierrez, N:
Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
Balari, AS:
Inst Catala Oncol ICO, Hematol Dept, Lhospitalet De Llobregat, Spain
Romero, MTC:
Hosp 12 Octubre, Hematol Dept, Madrid, Spain
:
Hosp Germans Trias i Pujol, Catalan Inst Oncol, Badalona, Spain
Hosp Germans Trias i Pujol, Josep Carreras Inst, Badalona, Spain
Ocio, E:
Univ Cantabria, Hosp Univ Marques de Valdecilla IDIVAL, Hematol Dept, Santander, Spain
Dachs, LR:
Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hematol Dept, Barcelona, Spain
Bargay, J:
Hosp Univ Son Llatzer, Hematol Dept, Palma De Mallorca, Spain
Blanchard, MJ:
Hosp Univ Ramon y Cajal, Hematol Dept, Madrid, Spain
Perianes, VC:
Univ Murcia, Virgen de la Arrixaca Univ Hosp, Hematol Dept, IMIB, El Palmar, Murcia, Spain
Palacios, JJL:
Hosp 12 Octubre, Hematol Dept, Madrid, Spain
Fdn PETHEMA, GEM, Madrid, Spain
Creixenti, JBB:
Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hematol Dept, Barcelona, Spain
Fdn PETHEMA, GEM, Madrid, Spain
San-Miguel, J:
Fdn PETHEMA, GEM, Madrid, Spain
Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain
Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain
Rodriguez-Otero, P:
Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain
Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain
Mateos, MV:
Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
Fdn PETHEMA, GEM, Madrid, Spain
Prosper, F:
Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain
Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain
|